Gilead Sciences (GILD) Shares Outstanding (Weighted Average) (2009 - 2026)

Gilead Sciences has reported Shares Outstanding (Weighted Average) for 18 years, with the latest figure at $1.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) changed 0.32% year-over-year to $1.2 billion; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (changed 0.32% YoY), and the FY2025 full-year result was $1.2 billion, changed 0.24% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $1.2 billion, roughly flat from $1.2 billion in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $1.3 billion in Q2 2022, with the low at $1.2 billion in Q1 2026.
• Historically, Shares Outstanding (Weighted Average) has averaged $1.2 billion across 5 years, with a median of $1.2 billion in 2024.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) changed 0.0% — and 2023, when it decreased 0.56%.
• Gilead Sciences' Shares Outstanding (Weighted Average) stood at $1.3 billion in 2022, then decreased by 0.56% to $1.2 billion in 2023, then declined by 0.08% to $1.2 billion in 2024, then dropped by 0.24% to $1.2 billion in 2025, then decreased by 0.16% to $1.2 billion in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $1.2 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.